HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates

Elicitation of broadly neutralizing antibody (bNAb) responses is a major goal for the development of an HIV-1 vaccine. Current HIV-1 envelope glycoprotein (Env) vaccine candidates elicit predominantly tier 1 and/or autologous tier 2 virus neutralizing antibody (NAb) responses, as well as weak and/or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Wang, Yimeng, O'Dell, Sijy, Turner, Hannah L., Chiang, Chi-I, Lei, Lin, Guenaga, Javier, Wilson, Richard, Martinez-Murillo, Paola, Doria-Rose, Nicole, Ward, Andrew B., Mascola, John R., Wyatt, Richard T., Karlsson Hedestam, Gunilla B., Li, Yuxing
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5640868/
https://ncbi.nlm.nih.gov/pubmed/28835491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00910-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados